Cargando…
Lumican in Carcinogenesis—Revisited
Carcinogenesis is a multifactorial process with the input and interactions of environmental, genetic, and metabolic factors. During cancer development, a significant remodeling of the extracellular matrix (ECM) is evident. Proteoglycans (PGs), such as lumican, are glycosylated proteins that particip...
Autores principales: | Giatagana, Eirini-Maria, Berdiaki, Aikaterini, Tsatsakis, Aristidis, Tzanakakis, George N., Nikitovic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466546/ https://www.ncbi.nlm.nih.gov/pubmed/34572532 http://dx.doi.org/10.3390/biom11091319 |
Ejemplares similares
-
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023) -
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020) -
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020) -
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
por: Berdiaki, Aikaterini, et al.
Publicado: (2021) -
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021)